St. Joseph Cancer Center - Clinical Trials: Brain
 

Glioblastoma:

  • RTOG 0825: Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
     

For more information on the above clinical trials: Cheryl Patz, RN, OCN, CCRC, 360.715.4133

 

Return to previous page

Cancer Services


Cancer Committee


Cancer Program